Document is current
Any future updates will be listed below
-
Authors
Boemer, François https://orcid.org/0000-0003-4470-9524
Hovhannesyan, Kristine https://orcid.org/0009-0001-4502-0502
Piazzon, Flavia
Minner, Frédéric
Mni, Myriam
Jacquemin, Valérie https://orcid.org/0000-0001-6281-8797
Mashhadizadeh, Davood https://orcid.org/0009-0008-4621-0173
Benmhammed, Noor
Bours, Vincent
Jacquinet, Adeline
Harvengt, Julie https://orcid.org/0000-0002-0127-1668
Bulk, Saskia
Dideberg, Vinciane https://orcid.org/0000-0002-9998-6687
Helou, Laura https://orcid.org/0000-0003-0608-5861
Palmeira, Leonor https://orcid.org/0009-0004-8750-6692
Dangouloff, Tamara
,
Alkan, Serpil
Barrea, Christophe
Bartoszek, Paulina
Bequet, Emeline
Boboli, Hedwige
Bruninx, Romain
Collard, Laure
Daron, Aurore
Debray, François-Guillaume
Dresse, Marie-Françoise
Dubru, Jean-Marie
Ebetiuc, Iulia
Florkin, Benoit
Jacquemart, Caroline
Kempeneers, Céline
Hennuy, Nadège
Lebrethon, Marie-Christine
Leonard, Marie
Leroy, Patricia
Lhomme, Angélique
Lombet, Jacques
Michotte, Sabine
Milet, Ariane
Parent, Anne-Simone
Rigo, Vincent
Seghaye, Marie-Christine
Vaessen, Sandrine
Servais, Laurent https://orcid.org/0000-0001-9270-4061
-
Funding
Funding for this research was provided by:
Service Public de Wallonie (1710180)
Sanofi (SGZ-2019-12843)
Takeda Pharmaceutical Company
Orchard Therapeutics Léon Frédéricq Foundation LaCAR MDx
- License Information
-
More Information
Article History
Received: 22 July 2024
Accepted: 12 December 2024
First Online: 28 January 2025
Competing interests
: F.B. has consulted for LaCAR MDx and has presented lectures for Novartis and Sanofi. T.D. has presented lectures for Biogen, Roche and Novartis. L.S. is a member of scientific advisory boards or has consulted for Biogen, Novartis, Roche, Illumina, Sanofi, Scholar Rock, LaCAR MDx and BioHaven. The other authors declare no competing interests.
